CANCER CAPITAL CORP.
CIK 0001130889
Revenue (TTM)
$0
Q3 Nov 2024
Net Income (TTM)
−$42.82K
+11.0% YoY
Q3 Nov 2024
EPS Diluted (TTM)
—
Q3 Nov 2024
Gross Margin
—
Q3 Nov 2024
Operating Margin
—
Q3 Nov 2024
Net Margin
—
Q3 Nov 2024
Free Cash Flow (TTM)
—
Q3 Nov 2024
Cash
$4.11K
Q3 Nov 2024
Total Debt
—
Q3 Nov 2024
Shares Outstanding
6.15M sh
Q3 Nov 2024
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.